Recombinant IATS O12 (Panobacumab Biosimilar) antibody
The Human Monoclonal anti-IATS O12 (Panobacumab Biosimilar) antibody is suitable to detect IATS O12 (Panobacumab Biosimilar) in samples from Pseudomonas aeruginosa. It has been validated for ELISA and WB.
Catalog No. ABIN7538055
$323.13
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant IATS O12 (Panobacumab Biosimilar) antibody (ABIN7538055)
Target
IATS O12 (Panobacumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Pseudomonas aeruginosa
Host
Human
Clonality
Monoclonal
Application
ELISA, Western Blotting (WB)
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Panobacumab Biosimilar - Anti-Serotype IATS O12 mAb - Research Grade
-
Characteristics
- Antibody Type: IgM-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Purity
- > 85%
-
Isotype
- IgM kappa
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS buffer PH7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- IATS O12 (Panobacumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
- Panobacumab (KBPA101) is a fully human IgM/κ monoclonal antibody generated by immortalizing human B lymphocytes against the LPS O polysaccharide of serotype O11 of P. Aeruginosa.
-
CAS-No
- 885053-97-4
Target
-
You are here:
